Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Journal of Cutaneous Pathology, 8(50), p. 748-753, 2023

DOI: 10.1111/cup.14440

Links

Tools

Export citation

Search in Google Scholar

Lymphatic vessel involvement in primary cutaneous B‐cell lymphoma: A common finding?

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractBackgroundCutaneous B‐cell lymphoma (CBCL) is part of dermatopathological routine diagnostics. However, in contrast to cutaneous T‐cell lymphomas, there are only a few studies on the prevalence and possible clinical impact of lymphatic vessel involvement. Therefore, this pilot study aimed to quantify the prevalence of lymphovascular involvement in CBCL and to assess the association between lymphovascular involvement and recurrence.MethodsThirty‐nine patients from two tertiary care hospitals diagnosed with CBCL were retrospectively identified and their biopsies were histopathologically examined for the presence of lymphatic vessel involvement using H&E stain, and CD20 and D2‐40 immunohistochemistry. Clinical data were retrieved from our digital documentation files.ResultsThirty patients were included in the evaluation (nPCFCL = 15, nPCMZL = 10, and nPCLBCL = 5). Lymphovascular involvement occurred in all three types of lymphoma and was present in 14/30 specimens. The presence of lymphatic involvement did not show a significant impact on recurrence rate (p = 0.150).ConclusionsThis immunohistochemical pilot study shows that lymphovascular involvement is a relatively frequent finding in primary CBCL. Although no definitive conclusion can be drawn from our findings because of the small sample size, there were no strong signs of tendencies for recurrence in either group. Future studies with larger sample size are warranted to assess the possible clinical implications.